BIERMAN JAMES L

SEC Form 4 insider trading activity

BIERMAN JAMES L has filed 3 SEC Form 4 filings (3 transaction rows) across 2 companies, including THC, MDXG, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jul 29, 2026.

On the most recent filing, BIERMAN JAMES L is listed as Director at TENET HEALTHCARE CORP. Inside the rolling window, BIERMAN JAMES L reported no open-market purchases and 1 open-market sale totaling $1.2M in THC.

Companies traded

Other insiders at THC

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.2M

reported sales (SEC code S)

Companies

2

in the rolling window

Source
THC
BIERMAN JAMES L
Sale$1.2MJul 29SEC ↗

Frequently asked questions

How many SEC Form 4 filings has BIERMAN JAMES L made?

BIERMAN JAMES L has filed 3 SEC Form 4 filings (3 transaction rows) across 2 companies, including THC, MDXG since 2026.

Which companies does BIERMAN JAMES L trade?

BIERMAN JAMES L has filed SEC Form 4 disclosures for 2 companies, including THC, MDXG.

When was BIERMAN JAMES L's most recent SEC Form 4 filing?

BIERMAN JAMES L's most recent SEC Form 4 filing on Tracefour is dated Jul 29, 2026.

What is BIERMAN JAMES L's total buy and sell value in the current window?

Inside the rolling retention window, BIERMAN JAMES L bought $0 and sold $1.2M based on SEC Form 4 filings.

What was BIERMAN JAMES L's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 5,000 THC shares on 2026-07-27, worth $1.2M, per SEC Form 4 filings.